Vimseltinib

Last Updated: 04/28/2026

Need to find the closest trial?
Sort By Distance
Save trials for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
2 clinical trials found

    A Phase 2, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, PK, and Efficacy of Vimseltinib in Adults With Active Chronic GVHD After Failure of Prior Systemic Therapy

    A Phase 2, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, PK, and Efficacy of Vimseltinib in Adults With Active Chronic GVHD After Failure of Prior Systemic Therapy

    Enrollment Status: Recruiting
    Publish Date: December 15, 2025
    Intervention Type: Drug
    Study Phase: Phase 2

    Summary: The purpose of this study is to determine if vimseltinib is safe, tolerable and works effectively to treat adults with active moderate to severe cGVHD. Participants will be treated with vimseltinib in 28-day treatment cycles for approximately 2 years.

    Real-World Patient Experience of Vimseltinib for the Treatment of Tenosynovial Giant Cell Tumor

    Real-World Patient Experience of Vimseltinib for the Treatment of Tenosynovial Giant Cell Tumor

    Enrollment Status: Recruiting
    Publish Date: November 05, 2025

    Summary: The goal of this observational study is to better understand real-world use of vimseltinib, treatment patterns, and health-related quality of life in participants treated with vimseltinib for TGCT. This study will collect data in an observational disease registry involving no intervention to the participants and will not influence standard medical care or impact treatment decisions for participant...

    Showing 1-2 of 2

    Last Updated: 04/28/2026